IRF4 and plasma cell myeloma: IRF4 is considered an oncogene in lymphoid malignancy and multiple myeloma [36], and Zhang et al. showed that overexpression of circPIP5K1A attenuated the expression of IRF4 in the progression of colon cancer development [37].